LUMEN BIOMEDICAL
Lumen Biomedical, Inc. develops and commercializes interventional devices for embolic protection and thrombus removal throughout the body. It offers FiberNet embolic protection systems for the treatment of patients receiving endovascular intervention for carotid artery diseases; and Xtract, a thrombus aspiration catheter device that supports the care of segment elevation myocardial infarction. The company’s products are used in carotid artery procedures. It serves customers through distributors in the United States and Europe. The company was founded in 2003 and is based in Maple Grove, Minnesota.
LUMEN BIOMEDICAL
Industry:
Biotechnology Health Care Medical Device
Founded:
2003-01-01
Address:
Maple Grove, Minnesota, United States
Country:
United States
Website Url:
http://www.lumenbio.com
Total Employee:
11+
Status:
Closed
Contact:
763-577-9600
Email Addresses:
[email protected]
Total Funding:
675 K USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Vector Internet Services
Similar Organizations
Accord Biomaterials
Accord Biomaterials, Inc. develops chemistries and coatings for medical device protection. It offers Nogen that are catalytic nitric oxide
Gradient Medical
Gradient Medical develops novel interventional oncology services to bring ACE therapy to the clinic.
Xillix
Xillix has develops and commercializes medical imaging technologies for detection and localization of cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.lumenbio.com
- Host name: a2b7bf3398455f345.awsglobalaccelerator.com
- IP address: 99.83.161.153
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Lumen Biomedical"
Homepage | Lumen Bioscience
Our goal is to transform the way such drugs are developed, what they cost, and who has access to them. Our patented technology allows us to develop biologic drugs faster and with lower …See details»
About | Lumen Bioscience
Lumen’s patented biologic drug platform shortens the development process, reduces costs and risks, and accelerates time-to-market, making us the first company to make orally delivered …See details»
Lumen Bioscience Details 2022 Company and Facilities Growth, …
Seattle, WA, January 5, 2023 – Lumen Bioscience — a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases — today provided a review of the …See details»
Lumen Bioscience - Crunchbase Company Profile
Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases. Lumen Bioscience develops and manufactures biologic drugs and vaccine …See details»
Lumen Bioscience - LinkedIn
Lumen Bioscience develops oral antibody therapeutics. COO and GC at Lumen Bioscience | 2xIPOs and 2x$1B+ M&A exits | Experienced General Counsel, Head of Corporate Development and Operating...See details»
Lumen Bio: ‘We face 2023 with tremendous optimism’
Jan 16, 2023 · Lumen Bioscience has been highlighting recent progress made on its clinical and regulatory journey while also announcing several funding milestones supporting the development of its therapeutics to prevent serious …See details»
Lumen Bioscience Announces Appointment of Marcos Milla, Ph.D …
Apr 22, 2021 · Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, today announced the appointment of Marcos …See details»
Lumen Bioscience Awarded Federal Funding to Advance Covid-19 …
SEATTLE, Oct. 6, 2021 /PRNewswire/ -- Lumen Bioscience —a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced new …See details»
Lumen Biomedical - Crunchbase Company Profile & Funding
Lumen Biomedical, Inc. develops and commercializes interventional devices for embolic protection and thrombus removal throughout the body. View contacts for Lumen Biomedical to …See details»
Lumen Bioscience: Spirulina-based platform enables …
Apr 7, 2022 · Researchers at Lumen Bioscience report in Nature Biotechnology genetic engineering methods to highly express bioactive proteins in spirulina using what they say are large-scale cultivation and processing methods …See details»
Science | Lumen Bioscience
We design and manufacture therapeutics against disease targets that have been inaccessible to the biopharmaceutical industry because of the astonishingly high cost of traditional methods. Now, for the first time, Lumen can make …See details»
Lumen Bioscience Receives Fast Track Designation from U.S
SEATTLE, May 17, 2023 /PRNewswire/ -- Lumen Bioscience —a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases—today announced that the …See details»
Lumen Bioscience Receives Fast Track Designation from U.S. FDA …
SEATTLE, May 17, 2023 /PRNewswire/ -- Lumen Bioscience —a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases—today announced that the …See details»
Lumen Biomedical Inc. | Insights
Jan 1, 2009 · By focusing first on peripherals and following with drug-eluting. The field of stroke moves slowly; 17 years elapsed between the introduction of the thrombolytic drug tPA, the first …See details»
Lumen Bio - Products, Competitors, Financials, Employees, …
Lumen Bio is a company focused on developing weight management products for pets within the biotechnology sector. Their main offering is a proprietary weight management solution …See details»
Lumen Bioscience Announces Clinical Advancement of LMN-201 …
Seattle, WA, April 18, 2022 – Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, today announced clinical development …See details»
Lumen Biomedical, Inc. | VentureRadar
Find out more about Lumen Biomedical, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Lumen Bioscience Announces Publication in Nature Biotechnology ...
Mar 21, 2022 · Researchers at Lumen Bioscience report in Nature Biotechnology their groundbreaking genetic engineering methods to highly express bioactive proteins in spirulina …See details»
Pipeline | Lumen Bioscience
Lumen is collaborating with Novo Nordisk, a global leader in CMD, to develop metabolically active molecules produced and delivered using spirulina.See details»
Lumen Bio Company Profile 2024: Valuation, Funding & Investors
Developer of a weight management technology designed to assist overweight companion animals. The company's technology uses antibodies targeting a protein in the stomach called …See details»